NCT02405104View on ClinicalTrials.gov

Chlorzoxazone in Hip and Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

July 31, 2019

Conditions
Osteoarthritis of HipOsteoarthritis, Knee
Interventions
DRUG

chlorzoxazone

ATC-code: M03BB03

DRUG

Placebo

Placebo

PROCEDURE

THA

Surgical treatment of osteoarthrosis in the hip, by replacement.

PROCEDURE

TKA

Surgical treatment of osteoarthrosis in the knee, by replacement.

Trial Locations (1)

Unknown

Northern Orthopaedic Division, Clinic Farsø, Aalborg University Hospital, Farsø

All Listed Sponsors
lead

Northern Orthopaedic Division, Denmark

OTHER

NCT02405104 - Chlorzoxazone in Hip and Knee Arthroplasty | Biotech Hunter | Biotech Hunter